Russell A Poldrack — Dr. Russell Poldrack's lab at Stanford University focuses on understanding mental health through the lens of cognitive science and neuroimaging. The team utilizes a data-driven approach to validate concepts related to attention, cognitive control, and working memory, assessing how these factors relate to brain networks and real-world behaviors. By integrating behavioral data with brain imaging, they aim to enhance existing frameworks for studying mental health disorders.
Brian K Kobilka — Dr. Brian Kobilka's lab at Stanford University focuses on understanding how G protein-coupled receptors (GPCRs) work. These receptors play a crucial role in receiving signals from neurotransmitters and hormones, which helps control various bodily functions. The lab's research aims to uncover the structural and dynamic properties of GPCRs, particularly in how they signal through different pathways, including those involved in pain relief and side effects from drugs like opioids. This knowledge can lead to the development of better and safer medications.
Ian H Gotlib — Dr. Ian Gotlib's lab studies how early life stress affects mental health and brain development from childhood through young adulthood. They focus on understanding the biological mechanisms linking stress to depression and other psychological issues. By examining diverse populations and the impact of events like the COVID-19 pandemic, the lab aims to identify risk factors and improve prevention strategies for youth mental health issues.
Stephen Joseph Galli — Dr. Stephen Joseph Galli's lab at Stanford University studies how genetic variations affect the immune responses of mast cells to honeybee venom. They aim to uncover how these immune responses can be both harmful, leading to allergic reactions, or beneficial, potentially offering protection against venom toxicity. Their research involves using genetically diverse mice to explore these pathways and identify ways to improve treatment for venom allergies and related disorders.
Thomas J Montine — Dr. Thomas J. Montine's lab at Stanford University focuses on understanding the molecular mechanisms behind Alzheimer's disease (AD) and related dementias. The lab employs advanced technologies, including innovative single-cell analyses and machine learning, to identify specific neuronal vulnerabilities and develop new therapeutic targets aimed at preventing or treating these conditions. Their research integrates genetic, anatomical, and pathological insights to provide a comprehensive view of AD and its impact on synaptic function.
Anshul Kundaje — Dr. Anshul Kundaje's lab at Stanford University focuses on understanding how genetic variations affect human health by studying the noncoding regions of the genome. The lab uses advanced machine learning techniques and innovative experimental methods to create detailed maps that show how genetic changes can influence cell behavior and contribute to diseases. Students in this lab will gain valuable experience in computational biology and functional genomics.
Michael Andrew Fischbach — Dr. Michael Fischbach's lab at Stanford University focuses on harnessing the power of the human microbiome to create innovative vaccines. By engineering certain beneficial bacteria to target diseases like cancer and autoimmune conditions, the lab aims to develop solutions that are effective, durable, and easy to distribute, particularly in low-resource settings. This research combines cutting-edge technologies from immunology and microbiology to redefine how vaccines can be designed and applied.
Helen M Blau — Dr. Helen M. Blau's lab at Stanford University focuses on understanding how aging affects muscle stem cells (MuSCs), which are crucial for muscle repair and regeneration. With the aging population facing challenges like sarcopenia, the lab investigates the mechanisms behind the decline in MuSC function and aims to enhance muscle regeneration through innovative technologies. The research combines cutting-edge single-cell analysis and in vivo experiments to uncover new therapeutic strategies to improve muscle health in elderly individuals.
Scott Dixon — Scott Dixon's lab at Stanford University focuses on understanding how specific cellular processes can lead to the death of small cell lung cancer (SCLC) cells. By studying the unique metabolism of these cancer cells, particularly how they handle cysteine—a vital amino acid—the lab aims to identify new therapeutic strategies to improve outcomes for SCLC patients. Researchers will explore the differences in cell death mechanisms based on the metabolic state of the cancer cells to develop targeted enzyme therapies.